[Effect of remantadine and amantadine on the interaction of influenza virus proteins with model lipid membranes]. 1988

I G Kharitonenkov, and S El Karadaghi, and A N Fedorov, and Iu A Zakomyrdin, and V A Tverdislov

The influence of adamantane derivatives (remantadine and amantadine) on the surface charge of lipid bilayer when they are adsorbed on an artificially formed bilayer lipid membrane (BLM) was studied. The presence of the final number of binding centres on the BLM surface for remantadine and amantadine molecules and the cooperative nature of interaction of these compounds with the lipid bilayer were demonstrated. The features of interaction of influenza virus proteins isolated from the virion--M protein and a mixture of surface glycoproteins--were studied. Both antiviral compounds were shown to reduce markedly M protein adsorption on the lipid bilayer and to affect negligibly the sorption properties of the surface glycoproteins. Remantadine molecules interact directly with M protein molecules reducing their hydrophobic properties and, thereby, reducing the affinity of this viral polypeptide to lipid bilayer.

UI MeSH Term Description Entries
D008051 Lipid Bilayers Layers of lipid molecules which are two molecules thick. Bilayer systems are frequently studied as models of biological membranes. Bilayers, Lipid,Bilayer, Lipid,Lipid Bilayer
D008562 Membrane Glycoproteins Glycoproteins found on the membrane or surface of cells. Cell Surface Glycoproteins,Surface Glycoproteins,Cell Surface Glycoprotein,Membrane Glycoprotein,Surface Glycoprotein,Glycoprotein, Cell Surface,Glycoprotein, Membrane,Glycoprotein, Surface,Glycoproteins, Cell Surface,Glycoproteins, Membrane,Glycoproteins, Surface,Surface Glycoprotein, Cell,Surface Glycoproteins, Cell
D008567 Membranes, Artificial Artificially produced membranes, such as semipermeable membranes used in artificial kidney dialysis (RENAL DIALYSIS), monomolecular and bimolecular membranes used as models to simulate biological CELL MEMBRANES. These membranes are also used in the process of GUIDED TISSUE REGENERATION. Artificial Membranes,Artificial Membrane,Membrane, Artificial
D009980 Influenza A virus The type species of the genus ALPHAINFLUENZAVIRUS that causes influenza and other diseases in humans and animals. Antigenic variation occurs frequently between strains, allowing classification into subtypes and variants. Transmission is usually by aerosol (human and most non-aquatic hosts) or waterborne (ducks). Infected birds shed the virus in their saliva, nasal secretions, and feces. Alphainfluenzavirus influenzae,Avian Orthomyxovirus Type A,FLUAV,Fowl Plague Virus,Human Influenza A Virus,Influenza Virus Type A,Influenza Viruses Type A,Myxovirus influenzae-A hominis,Myxovirus influenzae-A suis,Myxovirus pestis galli,Orthomyxovirus Type A,Orthomyxovirus Type A, Avian,Orthomyxovirus Type A, Human,Orthomyxovirus Type A, Porcine,Pestis galli Myxovirus,Fowl Plague Viruses,Influenza A viruses,Myxovirus influenzae A hominis,Myxovirus influenzae A suis,Myxovirus, Pestis galli,Myxoviruses, Pestis galli,Pestis galli Myxoviruses,Plague Virus, Fowl,Virus, Fowl Plague
D011995 Recombination, Genetic Production of new arrangements of DNA by various mechanisms such as assortment and segregation, CROSSING OVER; GENE CONVERSION; GENETIC TRANSFORMATION; GENETIC CONJUGATION; GENETIC TRANSDUCTION; or mixed infection of viruses. Genetic Recombination,Recombination,Genetic Recombinations,Recombinations,Recombinations, Genetic
D004347 Drug Interactions The action of a drug that may affect the activity, metabolism, or toxicity of another drug. Drug Interaction,Interaction, Drug,Interactions, Drug
D000218 Adamantane A tricyclo bridged hydrocarbon. Diamantane
D000327 Adsorption The adhesion of gases, liquids, or dissolved solids onto a surface. It includes adsorptive phenomena of bacteria and viruses onto surfaces as well. ABSORPTION into the substance may follow but not necessarily. Adsorptions
D000547 Amantadine An antiviral that is used in the prophylactic or symptomatic treatment of influenza A. It is also used as an antiparkinsonian agent, to treat extrapyramidal reactions, and for postherpetic neuralgia. The mechanisms of its effects in movement disorders are not well understood but probably reflect an increase in synthesis and release of dopamine, with perhaps some inhibition of dopamine uptake. 1-Aminoadamantane,Adamantylamine,Adekin,Aman,Amanta,Amanta-HCI-AZU,Amanta-Sulfate-AZU,Amantadin AL,Amantadin AZU,Amantadin Stada,Amantadin-neuraxpharm,Amantadin-ratiopharm,Amantadina Juventus,Amantadina Llorente,Amantadine Hydrochloride,Amantadine Sulfate,Amixx,Cerebramed,Endantadine,Gen-Amantadine,Infecto-Flu,Infex,Mantadix,Midantan,PMS-Amantadine,Symadine,Symmetrel,Viregyt,Wiregyt,tregor,1 Aminoadamantane,AL, Amantadin,AZU, Amantadin,Amanta HCI AZU,Amanta Sulfate AZU,AmantaHCIAZU,AmantaSulfateAZU,Amantadin neuraxpharm,Amantadin ratiopharm,Amantadinneuraxpharm,Amantadinratiopharm,Gen Amantadine,GenAmantadine,Hydrochloride, Amantadine,Infecto Flu,InfectoFlu,Juventus, Amantadina,Llorente, Amantadina,PMS Amantadine,PMSAmantadine,Stada, Amantadin,Sulfate, Amantadine
D012299 Rimantadine An RNA synthesis inhibitor that is used as an antiviral agent in the prophylaxis and treatment of influenza. Remantadine,Flumadine,Riamantadine,Rimantadine Hydrochloride,Roflual,Hydrochloride, Rimantadine

Related Publications

I G Kharitonenkov, and S El Karadaghi, and A N Fedorov, and Iu A Zakomyrdin, and V A Tverdislov
May 1990, Biulleten' eksperimental'noi biologii i meditsiny,
I G Kharitonenkov, and S El Karadaghi, and A N Fedorov, and Iu A Zakomyrdin, and V A Tverdislov
January 1981, Voprosy virusologii,
I G Kharitonenkov, and S El Karadaghi, and A N Fedorov, and Iu A Zakomyrdin, and V A Tverdislov
January 2006, The Journal of membrane biology,
I G Kharitonenkov, and S El Karadaghi, and A N Fedorov, and Iu A Zakomyrdin, and V A Tverdislov
January 1990, Biofizika,
I G Kharitonenkov, and S El Karadaghi, and A N Fedorov, and Iu A Zakomyrdin, and V A Tverdislov
January 1982, Voprosy virusologii,
I G Kharitonenkov, and S El Karadaghi, and A N Fedorov, and Iu A Zakomyrdin, and V A Tverdislov
January 1986, Voprosy virusologii,
I G Kharitonenkov, and S El Karadaghi, and A N Fedorov, and Iu A Zakomyrdin, and V A Tverdislov
January 1986, Voprosy virusologii,
I G Kharitonenkov, and S El Karadaghi, and A N Fedorov, and Iu A Zakomyrdin, and V A Tverdislov
January 1988, Voprosy virusologii,
I G Kharitonenkov, and S El Karadaghi, and A N Fedorov, and Iu A Zakomyrdin, and V A Tverdislov
January 1981, Voprosy meditsinskoi khimii,
I G Kharitonenkov, and S El Karadaghi, and A N Fedorov, and Iu A Zakomyrdin, and V A Tverdislov
July 1986, Acta virologica,
Copied contents to your clipboard!